Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Inhaled Vidaza® in Patients With Advanced NSCLC

NCT02009436 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT02009436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Inhaled Vidaza® in Patients With Advanced NSCLC
Lead sponsor
Albert Einstein College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
February 9, 2015
Completion date
July 18, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent non-small cell lung carcinoma, stage iv non-small cell lung cancer